Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Submitted by
admin
on October 29, 2011 - 12:46pm
Source:
Bloomberg
News Tags:
FDA
Vytorin
Merck
kidney disease
Headline:
Merck’s Vytorin Cuts Heart Risk in Kidney Patients, FDA Says
Do Not Allow Advertisers to Use My Personal information
